Ticker League

Operating Cash Flow for Amgen (AMGN)

As of · Reported

Metric

Latest period

$2.19B

YoY change

-13.3%

5Y CAGR

-1.0%

Peak year (2024)

$11.49B

Operating Cash Flow history chart for Amgen (AMGN) from 1988 to 2025

Latest: $9.96B

Operating Cash Flow growth chart for Amgen (AMGN) from 1988 to 2025

Latest: -13.3%

Operating Cash Flow history table for Amgen (AMGN) from 1988 to 2025

  • 2025$9.96B-13.3%
  • 2024$11.49B+35.6%
  • 2023$8.47B-12.9%
  • 2022$9.72B+5.0%
  • 2021$9.26B-11.8%
  • 2020$10.50B+14.7%
  • 2019$9.15B-19.0%
  • 2018$11.30B+1.1%
  • 2017$11.18B+7.9%
  • 2016$10.35B+14.1%
  • 2015$9.08B+6.1%
  • 2014$8.55B+36.0%
  • 2013$6.29B+7.0%
  • 2012$5.88B+14.9%
  • 2011$5.12B-11.5%
  • 2010$5.79B-8.7%
  • 2009$6.34B+5.8%
  • 2008$5.99B+10.9%
  • 2007$5.40B+0.2%
  • 2006$5.39B+9.7%
  • 2005$4.91B+32.8%
  • 2004$3.70B+3.7%
  • 2003$3.57B+58.6%
  • 2002$2.25B+51.9%
  • 2001$1.48B-9.4%
  • 2000$1.63B+52.0%
  • 1999$1.08B+3.2%
  • 1998$1.04B+15.4%
  • 1997$902.90M+9.8%
  • 1996$822.60M+6.4%
  • 1995$773.20M+45.4%
  • 1994$531.90M+22.8%
  • 1993$433.00M+47.9%
  • 1992$292.80M+33.3%
  • 1991$219.70M+1527.4%
  • 1990$13.50M-27.8%
  • 1989$18.70M-416.9%
  • 1988−$5.90M—

Operating Cash Flow values are taken from Amgen's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Operating Cash Flow at Amgen (AMGN)

Operating Cash Flow for Amgen (AMGN): headline value $2.19B · YoY -13.3%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

The 2025 reading of Amgen (AMGN) operating cash flow is $9.96B – declined 13.3% year-over-year.

Amgen operating cash flow has contracted on net over the period, with a -1.0% compound annual growth rate over 2020–2025 (5 years).

Amgen operating cash flow declined from $11.49B in 2024 to $9.96B in 2025, a 13.3% drawdown.

$11.49B stands as the all-time-high annual operating cash flow, posted in 2024, against a low of −$5.90M during 1988.

Amgen Operating Cash Flow by Year

Amgen Operating Cash Flow 2025: $9.96B

In 2025, Amgen reported operating cash flow of $9.96B, declined 13.3% below 2024.

Amgen Operating Cash Flow 2024: $11.49B

Amgen operating cash flow in 2024 was $11.49B, surged 35.6% from 2023. This figure represents the highest annual value in the available history.

Amgen Operating Cash Flow 2023: $8.47B

2023's operating cash flow for Amgen came in at $8.47B, declined 12.9% below 2022.

Amgen Operating Cash Flow 2022: $9.72B

Amgen posted operating cash flow of $9.72B in 2022, edged up 5.0% from 2021.

Amgen Operating Cash Flow 2021: $9.26B

Amgen operating cash flow in 2021 was $9.26B.

See more financial history for Amgen (AMGN).

Sector peers by Operating Cash Flow

Healthcare peers of Amgen (AMGN), ranked by their latest operating cash flow

Frequently asked questions

Amgen (AMGN) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation